USPTO serial 77122298
RITEDOSE PHARMACEUTICALS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROWN, BARBARA TROFFKIN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RITEDOSE PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marcia T. Greci
Marcia T. Greci Nelson Mullins Riley & Scarborough LLP100 North Tryon Street42nd Floor, IP DepartmentCharlotte, NC 28202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | toothpastes, non-medicated mouth washes, teeth whitening preparations | ACTIVE | — |
| 005 | Pharmaceutical oral liquids for the treatment of colds, allergies, coughs, sinus ailments, analgesics for pain management, fevers, gastrointestinal and digestive ailments, cardiovascular and circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, oral contraceptives, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections and infestations, neurological problems, insomnia, hair loss and immunologic ailments; Neutraceuticals, namely botanicals, carbohydrates, fiber supplements, lipids, fish oil, omega-3s, dietary supplements, vitamins, minerals, homeopathic remedies, proteins, natural growth hormone remedies, metabolites, and root, plant and herb extracts, for the treatment of vitamin and mineral deficiencies, fiber deficiencies, sports nutritional deficiencies, general nutritional deficiencies, immunity deficiencies, antioxidant deficiencies, protein deficiencies, colds and cold preventions, allergies, coughs, sinus ailments, digestive and diet issues, energy and vitality issues, joint and muscular-skeletal issues, cardiovascular and circulatory issues, memory issues, insomnia, urologic and urinary tract problems, hair loss, skin conditions, and hormone deficiencies; Medical liquids, namely, oral antibiotics, otic antibiotics, nasal saline drops and sprays, topical hand sanitizing preparations for oral delivery, eye delivery, nasal delivery, ear delivery, rectal, delivery, vaginal delivery, topical use, and/or for external delivery by syringes, crucibles and cups; veterinary medicine for dogs, cats, birds, fish and reptiles for the treatment of vitamin and mineral deficiencies, nutritional supplements, oral systemic and topical skin and ear antibiotics, parasite treatment, joint and muscular issues, oral and dental care, digestive aids and issues, namely, de-worming preparations, allergy problems, behavioral problems, eye and ear problems, and skin and coat care; dental and periodontal care products, namely, pharmaceutical oral liquids for the treatment of plaque, gingivitis, periodontitis and gum health issues in humans, felines, and canines, oral dental rinses, medicated mouth wash for plaque prevention, fluoride additives, and denture adhesives; liquid medical food, namely, processed food adapted for medical purposes, infant formula, infant gas relief, and dietary fiber as an additive for food products for the treatment of vitamin and mineral deficiencies, fiber deficiencies, digestive issues, tube feeding, weight control and/or nutritional feeding | ACTIVE | — |
| 010 | medical apparatus, namely, containers for pharmaceutical oral liquids, neutraceuticals, medical liquids, veterinary medicine, dental care products, and liquid medical foods | ACTIVE | — |
| 035 | Marketing consultation in the field of pharmaceuticals; packaging articles to the order and specification of others | ACTIVE | — |
| 039 | Packaging articles for transportation | ACTIVE | — |
| 040 | manufacturing services for others in the field of pharmaceutical oral liquids, neutraceuticals, medical liquids, veterinary medicine, dental care products, and liquid medical food | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by THE RITEDOSE CORPORATION
- Other trademarks owned by Holopack International Corp.
- Other trademarks owned by Holopack International Corp.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 040
- Similar marks named RITEDOSE PHARMACEUTICALS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 15, 2011 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 15, 2011 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 19, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 18, 2011 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 14, 2011 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 14, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 20, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 19, 2010 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 15, 2010 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 15, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 18, 2010 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 18, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 15, 2010 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 15, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 18, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 16, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 9, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 16, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 15, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 15, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 2, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 2, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 15, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 15, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 15, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 22, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 2, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 18, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 18, 2008 | ALIE | ASSIGNED TO LIE | — |
| Feb 28, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 28, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 10, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 6, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 6, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 8, 2007 | NWAP | NEW APPLICATION ENTERED | — |